Literature DB >> 16151787

[Lipid lowering drug and other toxic myopathies].

B G H Schoser1, D Pongratz.   

Abstract

A growing number of therapeutic agents and exogenous toxins are harmful to structure and function of human skeletal muscle. The clinical syndrome encompasses asymptomatic creatine kinase elevation, myalgia, exercise intolerance, muscle paresis and atrophy, and lastly acute rhabdomyolysis. Toxic myopathies are potentially reversible, hence a prompt recognition is particularly helpful for the early diagnosis and in conclusion elimination of a myopathy inducing toxin. Toxic myopathies may be classified as acute or chronic accordingly to the exposition time to a toxin. Main source of an exogenous induced toxic myopathy is chronic alcohol abuse. Alcohol excess induces acute and/or chronic neuropathy and myopathy, consequently muscle wasting and weakness occurs. Drug-induced myopathies are most frequently seen due to amplified utilization of corticosteroids or lipid lowering agents.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16151787     DOI: 10.1007/s00108-005-1490-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  30 in total

1.  Exercise and diet reduce risk of diabetes, US study shows.

Authors:  F Charatan
Journal:  BMJ       Date:  2001-08-18

2.  ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins.

Authors:  Richard C Pasternak; Sidney C Smith; C Noel Bairey-Merz; Scott M Grundy; James I Cleeman; Claude Lenfant
Journal:  Stroke       Date:  2002-09       Impact factor: 7.914

Review 3.  The diagnosis of mitochondrial muscle disease.

Authors:  Robert W Taylor; Andrew M Schaefer; Martin J Barron; Robert McFarland; Douglass M Turnbull
Journal:  Neuromuscul Disord       Date:  2004-04       Impact factor: 4.296

4.  Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease.

Authors:  R C Betz; B G Schoser; D Kasper; K Ricker; A Ramírez; V Stein; T Torbergsen; Y A Lee; M M Nöthen; T F Wienker; J P Malin; P Propping; A Reis; W Mortier; T J Jentsch; M Vorgerd; C Kubisch
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

5.  A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.

Authors:  D Sumi; T Hayashi; N K Thakur; M Jayachandran; Y Asai; H Kano; H Matsui; A Iguchi
Journal:  Atherosclerosis       Date:  2001-04       Impact factor: 5.162

Review 6.  [Fibrate and statine myopathy].

Authors:  J Finsterer
Journal:  Nervenarzt       Date:  2003-02       Impact factor: 1.214

7.  Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.

Authors:  David J Graham; Judy A Staffa; Deborah Shatin; Susan E Andrade; Stephanie D Schech; Lois La Grenade; Jerry H Gurwitz; K Arnold Chan; Michael J Goodman; Richard Platt
Journal:  JAMA       Date:  2004-11-22       Impact factor: 56.272

8.  Dermatomyositis-like syndrome and HMG-CoA reductase inhibitor (statin) intake.

Authors:  Olavo M Vasconcelos; William W Campbell
Journal:  Muscle Nerve       Date:  2004-12       Impact factor: 3.217

Review 9.  The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10. A review of animal and human publications.

Authors:  Peter H Langsjoen; Alena M Langsjoen
Journal:  Biofactors       Date:  2003       Impact factor: 6.113

10.  Caveolin, cholesterol, and lipid droplets?

Authors:  G van Meer
Journal:  J Cell Biol       Date:  2001-03-05       Impact factor: 10.539

View more
  4 in total

Review 1.  [Medication-induced dysphagia : A review].

Authors:  C Schwemmle; M Jungheim; S Miller; D Kühn; M Ptok
Journal:  HNO       Date:  2015-07       Impact factor: 1.284

Review 2.  [Medically induced myopathia].

Authors:  J Finsterer
Journal:  Nervenarzt       Date:  2006-06       Impact factor: 1.214

Review 3.  Position paper of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery and the German Society of Phoniatrics and Pediatric Audiology - Current state of clinical and endoscopic diagnostics, evaluation, and therapy of swallowing disorders in children.

Authors:  Christoph Arens; Ingo F Herrmann; Saskia Rohrbach; Cornelia Schwemmle; Tadeus Nawka
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

Review 4.  [Inflammatory myopathies].

Authors:  B Schoser
Journal:  Z Rheumatol       Date:  2009-10       Impact factor: 1.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.